BackiHuman Overview

iHuman Gross Profit

Track iHuman's gross profit ($400M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Gross Profit

$121.24M
↓ 15.68% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$402.33M
↓ 34.67% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

iHuman (IH) FAQ

The latest gross profit for IH is $400M as of March 2026. That compares with $620M in the prior-year period — down 34.7% year over year. That is below the sector sector average of $790M. Investors often review this figure alongside iHuman's historical trend and sector peers before judging valuation or financial health.

Over the past year, IH's gross profit moved from $620M to $400M — a 34.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in iHuman's operating scale or balance-sheet position.

Against its sector companies, IH currently prints $400M for gross profit, while the sector average sits near $790M. That is roughly 49.1% below the sector mean. Large gaps often invite a closer look at iHuman's growth, margins, and balance sheet.

A gross profit figure of $400M for IH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $790M. Explore the charts below for those layers of context.

After noting IH's gross profit ($400M), review year-over-year change from $620M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.